1 – 10 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
(
- Contribution to journal › Article
-
Mark
Metabolic pathways in immune senescence and inflammaging : Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
(
- Contribution to journal › Article
- 2023
-
Mark
Integrating innovations in asthma research into clinical practice
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Functional imaging for assessing regional lung ventilation in preclinical and clinical research
(
- Contribution to journal › Article
-
Mark
A EUFOREA comment on a lost comorbidity of asthma
(
- Contribution to journal › Letter
-
Mark
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
(
- Contribution to journal › Scientific review
-
Mark
Allergen immunotherapy for allergic asthma : The future seems bright
(
- Contribution to journal › Article
-
Mark
Evaluating treatment response to mepolizumab in patients with severe CRSwNP*
(
- Contribution to journal › Article
-
Mark
Pre-asthma : a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1—allergic asthma
(
- Contribution to journal › Scientific review
-
Mark
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma : An EAACI position paper
(
- Contribution to journal › Article